The Efficacy of Paclitaxel and Cisplatin Combination Chemotherapy for the Treatment of Metastatic or Recurrent Gastric Cancer: a Multicenter Phase II Study
Sang Joon Shin, Sung Ho Chun, Kyeong Ok Kim, Min Kyoung Kim, Kyung Hee Lee, Myung Soo Hyun, Sung Hwa Bae, Hun Mo Ryoo, Young Rok Do, Ki Young Kwon, Hong Suk Song
Korean J Intern Med. 2005;20(2):135-140. Published online 2005 Jun 30 DOI: https://doi.org/10.3904/kjim.2005.20.2.135
Citations to this article as recorded by 
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Aleksandra Zoń, Ilona Bednarek
International Journal of Molecular Sciences.2023; 24(8): 7585. CrossRef
A network embedding framework based on integrating multiplex network for drug combination prediction
Liang Yu, Mingfei Xia, Qi An
Briefings in Bioinformatics.2022;[Epub] CrossRef
3D printed drug-loaded implantable devices for intraoperative treatment of cancer
C. Tilden Hagan, Cameron Bloomquist, Samuel Warner, Nicole M. Knape, Isaiah Kim, Hayley Foley, Kyle T. Wagner, Sue Mecham, Joseph DeSimone, Andrew Z. Wang
Journal of Controlled Release.2022; 344: 147. CrossRef
Conversion Surgery for Stage IV Gastric Cancer
Fei Zhang, Xuanzhang Huang, Yongxi Song, Peng Gao, Cen Zhou, Zhexu Guo, Jinxin Shi, Zhonghua Wu, Zhenning Wang
Frontiers in Oncology.2019;[Epub] CrossRef
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
Sina Vatandoust, Tim Bright, Amitesh Chandra Roy, David Watson, Susan Gan, Jeff Bull, Muhammad Nazim Abbas, Christos Stelios Karapetis
BMJ Open.2019; 9(5): e026732. CrossRef
The long-term survival of stage IV gastric cancer patients with conversion therapy
Kazuya Yamaguchi, Kazuhiro Yoshida, Toshiyuki Tanahashi, Takao Takahashi, Nobuhisa Matsuhashi, Yoshihiro Tanaka, Kazuaki Tanabe, Hideki Ohdan
Gastric Cancer.2018; 21(2): 315. CrossRef
Second-line chemotherapy for advanced gastric cancer in Korea
Sun Kyung Baek, Si-Young Kim, Jae-heon Jeong, Kyung San Cho, Hwi-Joong Yoon
Gastric Cancer.2012; 15(4): 345. CrossRef
Systemic treatment of gastric cancer
Alessandro Morabito, Guido Carillio, Raffaele Longo
Critical Reviews in Oncology/Hematology.2009; 70(3): 216. CrossRef
Paclitaxel chemotherapy for the treatment of gastric cancer
Junichi Sakamoto, Takanori Matsui, Yasuhiro Kodera
Gastric Cancer.2009; 12(2): 69. CrossRef
A Phase II Trial of Paclitaxel, 5-fluorouracil (5-FU) and Cisplatin in Patients with Metastatic or Recurrent Gastric Cancer
Gun Hi Kang, Gwang Sil Kim, Hyo Rak Lee, Young Jin Yuh, Sung Rok Kim
Cancer Research and Treatment.2008; 40(3): 106. CrossRef
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
Keun-Wook Lee, Jee Hyun Kim, Tak Yun, Eun Kee Song, Im il Na, Hyunchoon Shin, So Yeon Oh, In Sil Choi, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Jong Seok Lee, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim
Journal of Korean Medical Science.2007; 22(Suppl): S115. CrossRef
Multicenter Phase II Trial of Combination Chemotherapy with Weekly Paclitaxel and 5-Fluorouracil for the Treatment of Advanced or Recurrent Gastric Carcinoma
M. Ninomiya, K. Kondo, K. Matsuo, N. Hirabayashi, H. Kojima, M. Kobayashi, S. Kawamura, T. Ando, N. Musha, H. Konno, N. Nagata, H. Usuki, Y. Miyashita, K. Oba, S. Morita, J. Sakamoto
Journal of Chemotherapy.2007; 19(4): 444. CrossRef